2024 Q3 Form 10-Q Financial Statement

#000173994024000028 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $63.69B $60.52B
YoY Change 29.86% 24.57%
Cost Of Revenue $47.57B $44.49B
YoY Change 41.4% 4.75%
Gross Profit $16.13B $16.03B
YoY Change 4.67% 162.37%
Gross Profit Margin 25.32% 26.49%
Selling, General & Admin $3.590B $3.684B
YoY Change -5.23% 7.28%
% of Gross Profit 22.26% 22.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $650.0M $738.0M
YoY Change -15.14% -2.25%
% of Gross Profit 4.03% 4.6%
Operating Expenses $3.590B $3.684B
YoY Change -5.23% -5.27%
Operating Profit $2.576B $2.412B
YoY Change 15.0% 8.6%
Interest Expense -$1.297B -$423.0M
YoY Change 242.22% 25.52%
% of Operating Profit -50.35% -17.54%
Other Income/Expense, Net -$376.0M -$375.0M
YoY Change 3.01% 3.31%
Pretax Income $1.192B $1.989B
YoY Change -35.22% 5.57%
Income Tax $367.0M $360.0M
% Of Pretax Income 30.79% 18.1%
Net Earnings $825.0M $1.629B
YoY Change -43.06% 11.58%
Net Earnings / Revenue 1.3% 2.69%
Basic Earnings Per Share $2.65 $5.51
Diluted Earnings Per Share $2.63 $5.45
COMMON SHARES
Basic Shares Outstanding 279.5M shares 284.1M shares
Diluted Shares Outstanding 281.4M shares 284.1M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.752B $7.856B
YoY Change -29.25% -24.87%
Cash & Equivalents $5.888B $6.788B
Short-Term Investments $864.0M $1.068B
Other Short-Term Assets $2.667B $2.664B
YoY Change 80.69% 89.34%
Inventory $5.083B $5.173B
Prepaid Expenses
Receivables $27.85B $25.11B
Other Receivables $0.00 $0.00
Total Short-Term Assets $49.22B $46.22B
YoY Change 42.6% 33.14%
LONG-TERM ASSETS
Property, Plant & Equipment $3.594B $3.551B
YoY Change -8.41% -8.57%
Goodwill $44.37B $44.26B
YoY Change -3.13% -3.39%
Intangibles $29.79B $30.18B
YoY Change -4.89% -4.85%
Long-Term Investments $15.27B $15.94B
YoY Change -19.52% -15.94%
Other Assets $3.180B $3.276B
YoY Change 1.05% -78.11%
Total Long-Term Assets $108.4B $109.2B
YoY Change -5.83% -5.3%
TOTAL ASSETS
Total Short-Term Assets $49.22B $46.22B
Total Long-Term Assets $108.4B $109.2B
Total Assets $157.6B $155.4B
YoY Change 5.34% 3.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.515B $9.275B
YoY Change 10.97% 14.9%
Accrued Expenses $8.920B $9.003B
YoY Change -7.74% 5.93%
Deferred Revenue
YoY Change
Short-Term Debt $1.635B $790.0M
YoY Change
Long-Term Debt Due $937.0M $927.0M
YoY Change -69.24% -79.93%
Total Short-Term Liabilities $57.06B $55.37B
YoY Change 21.25% 16.96%
LONG-TERM LIABILITIES
Long-Term Debt $30.23B $30.18B
YoY Change 7.6% 7.33%
Other Long-Term Liabilities $3.033B $3.538B
YoY Change 3.44% -83.52%
Total Long-Term Liabilities $3.033B $3.538B
YoY Change 3.44% -92.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.06B $55.37B
Total Long-Term Liabilities $3.033B $3.538B
Total Liabilities $115.3B $113.9B
YoY Change 11.03% 8.9%
SHAREHOLDERS EQUITY
Retained Earnings $42.48B $42.13B
YoY Change 3.66% 5.5%
Common Stock $31.19B $31.05B
YoY Change 2.04% 2.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.41B $29.41B
YoY Change 23.9% 27.58%
Treasury Stock Shares
Shareholders Equity $42.10B $41.33B
YoY Change
Total Liabilities & Shareholders Equity $157.6B $155.4B
YoY Change 5.34% 3.59%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $825.0M $1.629B
YoY Change -43.06% 11.58%
Depreciation, Depletion And Amortization $650.0M $738.0M
YoY Change -15.14% -2.25%
Cash From Operating Activities $46.00M $265.0M
YoY Change -98.37% -89.37%
INVESTING ACTIVITIES
Capital Expenditures $399.0M $370.0M
YoY Change -0.99% -6.8%
Acquisitions
YoY Change
Other Investing Activities -$377.0M -$270.0M
YoY Change -59.64% 1488.24%
Cash From Investing Activities -$776.0M -$640.0M
YoY Change -41.96% 54.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 439.0M -2.309B
YoY Change -117.07% 430.8%
NET CHANGE
Cash From Operating Activities 46.00M 265.0M
Cash From Investing Activities -776.0M -640.0M
Cash From Financing Activities 439.0M -2.309B
Net Change In Cash -291.0M -2.684B
YoY Change -73.13% -263.36%
FREE CASH FLOW
Cash From Operating Activities $46.00M $265.0M
Capital Expenditures $399.0M $370.0M
Free Cash Flow -$353.0M -$105.0M
YoY Change -114.57% -105.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 ci Non Investment Revenue
NonInvestmentRevenue
48308000000 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
278000000 usd
CY2023Q2 us-gaap Revenues
Revenues
48586000000 usd
CY2023Q2 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
-30000000 usd
CY2023Q2 ci Segment Revenues
SegmentRevenues
48616000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1884000000 usd
CY2023Q2 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
55000000 usd
CY2023Q2 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-4000000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
455000000 usd
CY2023Q2 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2294000000 usd
ci Non Investment Revenue
NonInvestmentRevenue
117167000000 usd
us-gaap Net Investment Income
NetInvestmentIncome
611000000 usd
us-gaap Revenues
Revenues
117778000000 usd
ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
61000000 usd
ci Segment Revenues
SegmentRevenues
117717000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2068000000 usd
ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
172000000 usd
ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-1823000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
843000000 usd
ci Transaction Related Costs
TransactionRelatedCosts
100000000 usd
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2919000 shares
ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
76000000 usd
ci Transaction Related Costs
TransactionRelatedCosts
7000000 usd
ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
6000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1460000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
281133000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2367000 shares
CY2024Q2 us-gaap Debt Current
DebtCurrent
1717000000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
378000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
747000000 usd
CY2023Q4 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding
0 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccountsPayableCurrent
CY2024Q2 us-gaap Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration
SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccountsPayableCurrent
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
usd
CY2024Q2 ci Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value
ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue
usd
ci Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value
ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue
usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
usd
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
usd
us-gaap Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
27000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
350000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
79000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1135000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3397000000 usd
us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
84000000 usd
us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
96000000 usd
us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
135000000 usd
us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
100000000 usd
ci Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
-467000000 usd
ci Proceeds From Repayments Of Other Short Term Debt
ProceedsFromRepaymentsOfOtherShortTermDebt
183000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
80000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4462000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1491000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5012000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1116000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
221000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
59000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
793000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
730000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-198000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-275000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4838000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-472000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-12000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-880000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3660000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8337000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5976000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
625000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6832000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9636000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
567000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
926000000 usd
us-gaap Interest Paid Net
InterestPaidNet
643000000 usd
us-gaap Interest Paid Net
InterestPaidNet
632000000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-bottom:10pt"><span id="id99bd35dae21465297a1d2fbd4eff826_4265"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 – Description of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. Powered by our people and our brands, we advance our mission to improve the health and vitality of those we serve. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. The majority of these products and services are offered through employers and other entities such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers health and dental insurance and Medicare products to individuals in the United States and select international markets. In addition to these operations, The Cigna Group also has certain run-off operations.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A full description of our segments follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Evernorth Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment includes the Pharmacy Benefit Services and the Specialty and Care Services operating segments, which partner with health plans, employers, governmental organizations and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through Care Delivery and Management Solutions. The Company's reporting units remain aligned with its operating segments and Evernorth Health Services' goodwill was allocated on a relative fair value basis.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and specialty benefits and solutions for insured and self-insured clients, Medicare Advantage, Medicare Supplement and Medicare Stand-Alone Prescription Drug Plans for seniors and individual health insurance plans. International Health provides health care solutions in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2024, the Company entered into a definitive agreement to sell the Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits and CareAllies businesses within the <span style="-sec-ix-hidden:f-508">U.S. Healthcare</span> operating segment to Health Care Service Corporation ("HCSC") for approximately $3.3 billion cash, subject to applicable regulatory approvals and other customary closing conditions (the "HCSC transaction"). See Note 5 to the Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> comprises the remainder of our business operations, which includes our continuing business (corporate-owned life insurance ("COLI")) and our run-off and other non-strategic businesses. Our run-off businesses include (i) variable annuity reinsurance business that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses which were sold through reinsurance agreements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate financing less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and eliminations for products and services sold between segments.</span></div>
CY2024Q2 ci Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
12555000000 usd
CY2023Q4 ci Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
8169000000 usd
CY2024Q2 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
10946000000 usd
CY2023Q4 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale
8044000000 usd
CY2024Q2 ci Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale
InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale
2325000000 usd
CY2023Q4 ci Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale
InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale
2359000000 usd
CY2024Q2 ci Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
289000000 usd
CY2023Q4 ci Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
272000000 usd
CY2024Q2 ci Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
26115000000 usd
CY2023Q4 ci Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale
ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale
18844000000 usd
CY2024Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
25111000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
17722000000 usd
CY2024Q2 ci Allowance For Receivables Current
AllowanceForReceivablesCurrent
4400000000 usd
CY2023Q4 ci Allowance For Receivables Current
AllowanceForReceivablesCurrent
3700000000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90000000 usd
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Initial Term
AccountsReceivableUncommittedFactoringFacilityInitialTerm
P2Y
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Automatic Renewal Term
AccountsReceivableUncommittedFactoringFacilityAutomaticRenewalTerm
P1Y
CY2023Q3 ci Accounts Receivable Uncommitted Factoring Facility Total Capacity
AccountsReceivableUncommittedFactoringFacilityTotalCapacity
1000000000.0 usd
CY2024Q2 ci Accounts Receivable Uncommitted Factoring Facility Total Capacity
AccountsReceivableUncommittedFactoringFacilityTotalCapacity
1500000000 usd
CY2024Q2 ci Accounts Receivable Uncommitted Factoring Facility Amount Sold
AccountsReceivableUncommittedFactoringFacilityAmountSold
1300000000 usd
ci Accounts Receivable Uncommitted Factoring Facility Amount Sold
AccountsReceivableUncommittedFactoringFacilityAmountSold
3200000000 usd
CY2024Q2 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding
322000000 usd
CY2024Q2 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted
713000000 usd
CY2023Q4 ci Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted
AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted
515000000 usd
CY2024Q2 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
1700000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
1500000000 usd
CY2024Q2 ci Supplier Finance Program Outstanding Payment Obligation Current Voluntarily Elected To Be Sold
SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold
348000000 usd
CY2024Q2 ci Transaction Related Costs
TransactionRelatedCosts
63000000 usd
CY2024Q2 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
47000000 usd
ci Transaction Related Costs
TransactionRelatedCosts
100000000 usd
ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
76000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1548000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1548000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1460000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
281133000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
281133000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
294512000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
294512000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2919000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2367000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2367000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
284052000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
294512000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296879000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.51
CY2024Q2 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.06
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.45
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.96
CY2023Q2 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.92
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1271000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1271000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2727000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2727000000 usd
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
283799000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
295105000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3085000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2831000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
283799000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
286884000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
295105000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
297936000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.48
ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.24
ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.15
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
122500000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
107400000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
103300000 shares
CY2024Q2 us-gaap Commercial Paper
CommercialPaper
790000000 usd
CY2023Q4 us-gaap Commercial Paper
CommercialPaper
1237000000 usd
CY2024Q2 ci Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current
OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
42000000 usd
CY2023Q4 ci Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current
OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent
42000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
2775000000 usd
CY2024Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
52000000 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
66000000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
30175000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
28155000000 usd
srt Commercial Paper Average Rate Paid
CommercialPaperAverageRatePaid
0.0547
CY2024Q1 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
1800000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
350000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.40
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
401000000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.40
CY2024Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
392000000 usd
us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company's insurance and contractholder liabilities were comprised of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unpaid claims and claim expenses</span></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,336 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future policy benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">596</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">615 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">595 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,362</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,375 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,538 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,587 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractholder deposit funds</span></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cigna Healthcare</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Operations</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">360</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,381</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">362 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,178 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,540 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,647 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market risk benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">840</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">865</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,069 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned premiums</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">737</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">765</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">868 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,425 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,673</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,949</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,622</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,633 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,421 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,054 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance and contractholder liabilities classified as liabilities of businesses held for sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,057)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(500)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,557)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,119)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(517)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,636)</span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total insurance and contractholder liabilities</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,616</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,449</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,514 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,904 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,418 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,114 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Amounts classified as liabilities of businesses held for sale include $900 million of Unpaid claims, $417 million of Future policy benefits, $129 million of Unearned premiums and $111 million of Contractholder deposit funds as of June 30, 2024 and $823 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">of Unpaid claims, $429 million of Future policy benefits, $261 million of Unearned premiums and $123 million of Contractholder deposit funds as of December 31, 2023.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.707%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,092</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,176 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">221 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance, net</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,955 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred costs related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,821</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,974 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,537</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,772 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid costs related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,408 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,960</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,357</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,607 </span></td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,120 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Add: Reinsurance and other amounts recoverable</span></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">166</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216 </span></td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,202</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,336 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> Includes unpaid claims amounts classified as liabilities of businesses held for sale. As of June 30, 2024</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">and December 31, 2023, $900 million and $823 million classified as liabilities of businesses held for sale, respectively.</span></div>
CY2024Q2 ci Market Risk Benefit Liability Amount Current
MarketRiskBenefitLiabilityAmountCurrent
25000000 usd
CY2024Q2 ci Market Risk Benefit Liability Amount Noncurrent
MarketRiskBenefitLiabilityAmountNoncurrent
840000000 usd
CY2024Q2 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
865000000 usd
CY2023Q4 ci Market Risk Benefit Liability Amount Current
MarketRiskBenefitLiabilityAmountCurrent
37000000 usd
CY2023Q4 ci Market Risk Benefit Liability Amount Noncurrent
MarketRiskBenefitLiabilityAmountNoncurrent
966000000 usd
CY2023Q4 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
1003000000 usd
CY2023Q2 us-gaap Market Risk Benefit Liability Amount
MarketRiskBenefitLiabilityAmount
1069000000 usd
CY2024Q2 ci Unearned Premiums Current Including Disposal Groups
UnearnedPremiumsCurrentIncludingDisposalGroups
737000000 usd
CY2024Q2 ci Unearned Premiums Noncurrent Including Disposal Groups
UnearnedPremiumsNoncurrentIncludingDisposalGroups
28000000 usd
CY2024Q2 ci Unearned Premiums Including Disposal Groups
UnearnedPremiumsIncludingDisposalGroups
765000000 usd
CY2023Q4 ci Unearned Premiums Current Including Disposal Groups
UnearnedPremiumsCurrentIncludingDisposalGroups
846000000 usd
CY2023Q4 ci Unearned Premiums Noncurrent Including Disposal Groups
UnearnedPremiumsNoncurrentIncludingDisposalGroups
22000000 usd
CY2023Q4 ci Unearned Premiums Including Disposal Groups
UnearnedPremiumsIncludingDisposalGroups
868000000 usd
CY2023Q2 us-gaap Unearned Premiums
UnearnedPremiums
1425000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities Current Including Disposal Groups
InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups
6673000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups
InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups
10949000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities Including Disposal Groups
InsuranceAndContractholderLiabilitiesIncludingDisposalGroups
17622000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Current Including Disposal Groups
InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups
6633000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups
InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups
11421000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Including Disposal Groups
InsuranceAndContractholderLiabilitiesIncludingDisposalGroups
18054000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5616000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10449000000 usd
CY2024Q2 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
16065000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
5514000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
10904000000 usd
CY2023Q4 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
16418000000 usd
CY2023Q2 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
19114000000 usd
CY2024Q2 ci Policyholder Contract Balance Percent Reinsured Externally
PolicyholderContractBalancePercentReinsuredExternally
0.38
ci Annuitization Election Period
AnnuitizationElectionPeriod
P30D
CY2023Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1003000000 usd
CY2022Q4 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1268000000 usd
CY2023Q4 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1085000000 usd
CY2022Q4 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1379000000 usd
ci Market Risk Benefit Increase Decrease Due To Expected Run Off
MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
-6000000 usd
ci Market Risk Benefit Increase Decrease Due To Expected Run Off
MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff
-14000000 usd
ci Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change
MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
-133000000 usd
ci Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change
MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange
-194000000 usd
us-gaap Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected
MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
-17000000 usd
us-gaap Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected
MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected
8000000 usd
us-gaap Market Risk Benefit Increase Decrease From Other Assumption
MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
0 usd
us-gaap Market Risk Benefit Increase Decrease From Other Assumption
MarketRiskBenefitIncreaseDecreaseFromOtherAssumption
-32000000 usd
CY2024Q2 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
929000000 usd
CY2023Q2 us-gaap Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change
MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange
1147000000 usd
CY2024Q2 us-gaap Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax
AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
64000000 usd
CY2023Q2 us-gaap Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax
AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax
78000000 usd
CY2024Q2 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
865000000 usd
CY2023Q2 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
1069000000 usd
CY2024Q2 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
927000000 usd
CY2023Q2 us-gaap Market Risk Benefit Reinsurance Recoverable After Allowance
MarketRiskBenefitReinsuranceRecoverableAfterAllowance
1143000000 usd
CY2024Q2 ci Reinsurance Recoverables Gross Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverablesGrossBeforeReclassificationToDisposalGroupAssetsHeldForSale
4087000000 usd
CY2024Q2 ci Reinsurance Recoverable Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverableAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
34000000 usd
CY2024Q2 ci Reinsurance Recoverables Including Reinsurance Premium Paid Before Reclassification To Disposal Group Assets Held For Sale
ReinsuranceRecoverablesIncludingReinsurancePremiumPaidBeforeReclassificationToDisposalGroupAssetsHeldForSale
4980000000 usd
CY2024Q2 ci Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale
ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
1162000000 usd
CY2024Q2 ci Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
17251000000 usd
CY2024Q2 ci Investments Before Reclassification To Disposal Group Assets Held For Sale
InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
18413000000 usd
CY2023Q4 ci Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale
ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
1009000000 usd
CY2023Q4 ci Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
19339000000 usd
CY2023Q4 ci Investments Before Reclassification To Disposal Group Assets Held For Sale
InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
20348000000 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
1068000000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
15944000000 usd
CY2024Q2 us-gaap Investments
Investments
17012000000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
925000000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
17985000000 usd
CY2023Q4 us-gaap Investments
Investments
18910000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale
666000000 usd
CY2024Q2 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale
643000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale
3732000000 usd
CY2024Q2 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale
3497000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale
3175000000 usd
CY2024Q2 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale
2945000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale
2137000000 usd
CY2024Q2 ci Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale
1913000000 usd
CY2024Q2 ci Debt Securities Available For Sale Maturity Without Single Maturity Date Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
387000000 usd
CY2024Q2 ci Debt Securities Available For Sale Maturity Without Single Maturity Date Fair Value Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale
352000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10097000000 usd
CY2024Q2 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9350000000 usd
CY2024Q2 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10097000000 usd
CY2024Q2 ci Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
90000000 usd
CY2024Q2 ci Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
124000000 usd
CY2024Q2 ci Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
781000000 usd
CY2024Q2 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9350000000 usd
CY2023Q4 ci Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
10379000000 usd
CY2023Q4 ci Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
33000000 usd
CY2023Q4 ci Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
195000000 usd
CY2023Q4 ci Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale
686000000 usd
CY2023Q4 ci Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale
9855000000 usd
CY2024Q2 ci Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale
6712000000 usd
CY2024Q2 ci Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
7493000000 usd
CY2024Q2 ci Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
781000000 usd
CY2024Q2 ci Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale
2491 position
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale
6633000000 usd
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale
7319000000 usd
CY2023Q4 ci Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale
686000000 usd
CY2023Q4 ci Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale
2353 position
CY2024Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
655000000 usd
CY2024Q2 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
46000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
656000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
51000000 usd
CY2024Q2 ci Equity Securities Without Readily Determinable Fair Value Amortized Cost
EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
3313000000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1562000000 usd
CY2023Q4 ci Equity Securities Without Readily Determinable Fair Value Amortized Cost
EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost
3248000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
3311000000 usd
CY2024Q2 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
3968000000 usd
CY2024Q2 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
1608000000 usd
CY2023Q4 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost
3904000000 usd
CY2023Q4 ci Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount
EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount
3362000000 usd
CY2024Q2 ci Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
4446000000 usd
CY2023Q4 ci Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale
OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale
4181000000 usd
CY2024Q2 ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
13000000 usd
CY2023Q2 ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
31000000 usd
ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
7000000 usd
ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
-20000000 usd
CY2024Q2 ci Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total
DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal
61000000 usd
CY2023Q2 ci Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total
DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal
5000000 usd
ci Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total
DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal
1891000000 usd
ci Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total
DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal
10000000 usd
CY2024Q2 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-48000000 usd
CY2023Q2 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
26000000 usd
ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-1884000000 usd
ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-30000000 usd
CY2024Q2 ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
-2000000 usd
CY2023Q2 ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
-6000000 usd
ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
-6000000 usd
ci Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss
-5000000 usd
CY2024Q2 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
572000000 usd
CY2023Q4 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
578000000 usd
CY2024Q2 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6201000000 usd
CY2023Q4 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6172000000 usd
CY2024Q2 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
6773000000 usd
CY2023Q4 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
6750000000 usd
CY2024Q2 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
658000000 usd
CY2023Q4 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
680000000 usd
CY2024Q2 us-gaap Separate Account Assets
SeparateAccountAssets
7431000000 usd
CY2023Q4 us-gaap Separate Account Assets
SeparateAccountAssets
7430000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.181
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192
CY2024Q2 ci Deferred Tax Assets Investments Subject To Federal Capital Loss Utilization Rules
DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules
689000000 usd
CY2024Q2 ci Deferred Tax Assets Valuation Allowance Investments Subject To Federal Capital Loss Utilization Rules
DeferredTaxAssetsValuationAllowanceInvestmentsSubjectToFederalCapitalLossUtilizationRules
422000000 usd
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Financial Guarantees: Retiree and Life Insurance Benefits</span>The Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.An additional liability is established if management believes that the Company will be required to make payments under the guarantees;Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.84pt;text-decoration:underline">Certain Other Guarantees</span>The Company had indemnification obligations as of June 30, 2024 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with laws or regulations or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a stated dollar amount or a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:8.28pt;text-decoration:underline">Guaranty Fund Assessments</span><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</span></div>
CY2024Q2 ci Transaction Related Costs
TransactionRelatedCosts
63000000 usd
CY2024Q2 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
47000000 usd
CY2023Q2 ci Transaction Related Costs
TransactionRelatedCosts
6000000 usd
CY2023Q2 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
5000000 usd
ci Transaction Related Costs
TransactionRelatedCosts
100000000 usd
CY2024Q2 ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
0 usd
CY2024Q2 ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
0 usd
CY2023Q2 ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
0 usd
CY2023Q2 ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
0 usd
ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
-19000000 usd
ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
43000000 usd
ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
0 usd
ci Special Item Gain Loss On Sale Of Business Net Of Tax
SpecialItemGainLossOnSaleOfBusinessNetOfTax
0 usd
CY2024Q2 ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
CY2024Q2 ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
17000000 usd
CY2023Q2 ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
CY2023Q2 ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
0 usd
ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
34000000 usd
ci Special Item Charge Benefit Tax Matters
SpecialItemChargeBenefitTaxMatters
0 usd
ci Special Item Charge Benefit Tax Matters After Tax
SpecialItemChargeBenefitTaxMattersAfterTax
0 usd
CY2024Q2 ci Special Item Gain Or Loss Before Tax Attributable To Reporting Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity
-63000000 usd
CY2024Q2 ci Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity
-64000000 usd
CY2023Q2 ci Special Item Gain Or Loss Before Tax Attributable To Reporting Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity
-6000000 usd
CY2023Q2 ci Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity
-5000000 usd
ci Special Item Gain Or Loss Before Tax Attributable To Reporting Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity
-119000000 usd
ci Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity
-67000000 usd
ci Special Item Gain Or Loss Before Tax Attributable To Reporting Entity
SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity
-7000000 usd
ci Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity
SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity
-6000000 usd
CY2024Q2 ci Non Investment Revenue
NonInvestmentRevenue
60202000000 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
321000000 usd
CY2024Q2 us-gaap Revenues
Revenues
60523000000 usd
CY2024Q2 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
53000000 usd
CY2024Q2 ci Segment Revenues
SegmentRevenues
60470000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1989000000 usd
CY2024Q2 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
95000000 usd
CY2024Q2 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
5000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
420000000 usd
CY2024Q2 ci Transaction Related Costs
TransactionRelatedCosts
63000000 usd
CY2024Q2 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2372000000 usd
CY2023Q2 ci Transaction Related Costs
TransactionRelatedCosts
6000000 usd
ci Special Item Gain Loss On Sale Of Business Before Taxes
SpecialItemGainLossOnSaleOfBusinessBeforeTaxes
-19000000 usd
ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4681000000 usd
ci Non Investment Revenue
NonInvestmentRevenue
94548000000 usd
us-gaap Net Investment Income
NetInvestmentIncome
555000000 usd
us-gaap Revenues
Revenues
95103000000 usd
ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
8000000 usd
ci Segment Revenues
SegmentRevenues
95095000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3485000000 usd
ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
98000000 usd
ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-22000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
914000000 usd
ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4330000000 usd
CY2024Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
11454000000 usd
CY2023Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
11039000000 usd
us-gaap Premiums Earned Net
PremiumsEarnedNet
23057000000 usd
us-gaap Premiums Earned Net
PremiumsEarnedNet
22064000000 usd
CY2024Q2 ci Non Investment Revenue
NonInvestmentRevenue
60202000000 usd
CY2023Q2 ci Non Investment Revenue
NonInvestmentRevenue
48308000000 usd
ci Non Investment Revenue
NonInvestmentRevenue
117167000000 usd
ci Non Investment Revenue
NonInvestmentRevenue
94548000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001739940-24-000028-index-headers.html Edgar Link pending
0001739940-24-000028-index.html Edgar Link pending
0001739940-24-000028.txt Edgar Link pending
0001739940-24-000028-xbrl.zip Edgar Link pending
ci-20240630.htm Edgar Link pending
ci-20240630.xsd Edgar Link pending
ci-20240630_g1.jpg Edgar Link pending
exh_311x24q2.htm Edgar Link pending
exh_312x24q2.htm Edgar Link pending
exh_321x24q2.htm Edgar Link pending
exh_322x24q2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
ci-20240630_cal.xml Edgar Link unprocessable
ci-20240630_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ci-20240630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ci-20240630_pre.xml Edgar Link unprocessable
ci-20240630_lab.xml Edgar Link unprocessable